Global Trust Asset Management LLC Has $600,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Global Trust Asset Management LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,149 shares of the medical equipment provider’s stock after buying an additional 333 shares during the period. Global Trust Asset Management LLC’s holdings in Intuitive Surgical were worth $600,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth $36,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter worth $38,000. Finally, DT Investment Partners LLC lifted its stake in Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 1,012 shares of the firm’s stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $514.00, for a total value of $520,168.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,830,084. This trade represents a 15.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,509 shares of company stock worth $22,602,212. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $604.12 on Wednesday. The stock’s fifty day moving average price is $543.14 and its two-hundred day moving average price is $501.89. The firm has a market cap of $215.17 billion, a PE ratio of 97.13, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $362.14 and a one year high of $606.27.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of research analyst reports. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Wells Fargo & Company increased their price target on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Finally, BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.